Article Details
Retrieved on: 2022-11-08 16:26:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Background: Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 ...
Article found on: pubmed.ncbi.nlm.nih.gov
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here